Factors influencing response to treatment of pulmonary tuberculosis

Acta Medica Okayama

Volumn 54, Issue 4, 2000, Pages 139-145

  Hiyama, Junichiro ^a   Marukawa, Masaomi ^a   Shiota, Yutaro ^a   Ono, Tetsuya ^a   Mashiba, Hiroto ^a  

^a Kure Kyosai Hospital   (Japan)

Author keywords

Drug resistant tuberculosis; Multivariate analysis; Recursive partitioning and amalgamation (RPA)

Indexed keywords

TUBERCULOSTATIC AGENT;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TIME;

AGED; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0034241892     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bloom BR and Murray CJL: Tuberculosis: Commentary on a reemergent killer. Science (1992) 257, 1055-1064.
2. Centers for Disease Control: Meeting the challenge of multidrug-resistant tuberculosis: Summary of a conference. Morb Mortal Wkly Rep (1992) 41, 51-57.
3. Brudney K and Dobkin J: Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis (1991) 144, 745-749.
4. Glassroth J: Tuberculosis in the United States: Looking for a silver lining among the clouds. Am Rev Respir Dis (1992) 146, 278-279.
5. Pablos-Mendez A, Raviglione MC, Battan R and Ramons-Zuniga R: Drug resistant tuberculosis among the homeless in New York City. NY State J Med (1990) 90, 351-355.
6. Hobby GL, Johnson PM and Boytar-Papirnyik: V. Primary drug resistance: A continuing study of drug resistance in tuberculosis in a veteran population in the United States - September 1962 to September 1971, in Transactions of the 31st VA - Armed Forces Pulmonary Disease Research Conference, Cincinnati, January 24-25, 1972. Government Printing Office, Washington, DC, (1972) pp36-41.
7. Hobby GL, Johnson PM and Boytar-Papirnyik: V. Primary drug resistance: A continuing study of drug resistance in tuberculosis in a veteran population within the United States. September 1970 to September 1973. Am Rev Respir Dis (1974) 110, 95-98.
8. Cauthen GM, Kilburn JO, Kelly GD and Good RC: Resistance to antituberculosis drugs in patients with and without prior treatment: Survey of 31 state and large city laboratories, 1982-1986. Am Rev Respir Dis (1988) 137, S260.
9. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L and Horsburgh CR Jr : Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med (1993) 328, 527 532.
10. Ogata H: 8. Drug resistance among previously treated tuberculosis patients; in Manual of Medical Care Standards of Tuberculosis. Kekkakuyoboukai, Tokyo (1997) pp92-102 (in Japanese).
11. Rieder HL, Cauthen GM, Comstock GW and Snider DE Jr: Epidemiology of tuberculosis in the United States. Epidemiol Rev (1989) 11, 79-98.
12. American Thoracic Society: Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis (1990) 142, 725-735.
13. Ciampi A, Lawless JF, McKinney SM and Singhal K: Regression and recursive partition strategies in the analysis of medical survivial data. J Clin Epidemiol (1988) 41, 737-748.
14. Nippon Kekkakubyou Gakkai Chiryou linkai: Standard initial treatment of pulmonary tuberculosis; in Manual of Medical Care Standards of Tuberculosis. Kekkakuyoboukai, Tokyo (1997) pp162-166 (in Japanese).
15. Health and Welfare Statistics Association: Kekkaku. Kousei no Shihyou (1997) 44, 166-171 (in Japanese).
16. Koushu Eisei Shingikai: The official statement of public health committee. Revision of activity classification and medical care standards of tuberculosis; in Manual of Medical Care Standards of Tuberculosis. Kekkakuyoboukai, Tokyo (1997) pp157-161 (in Japanese).
17. American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis (1986) 134, 355-363.
18. The Committee on Treatment of the International Union Against Tuberculosis and Lung Disease: Antituberculosis regimens of chemotherapy. Bull IUATLD (1988) 63, 60-64.
19. Steele MA and DesPrez RM: The role of pyrazinamide in tuberculosis chemotherapy. Chest (1988) 94, 845-850.
20. WHO: Guidelines for tuberculosis treatment in adults and children in national tuberculosis. WHO/TUB (1991) 91, 161.
21. Singapore Tuberculosis Service/British Medical Research Council: Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: The results up to 30 months. Tubercle (1981) 62, 95-102.
22. Third East African/British Medical Research Council Study: Controlled clinical trial of four short-course regimens of chemotherapy for two duration in the treatment of pulmonary tuberculosis. First report: Research Councils Study. Am Rev Respir Dis (1978) 118, 39-48.
23. British Thoracic Association: A controlled trial of six months chemothrapy in pulmonary tuberculosis. Br J Dis Chest (1981) 75, 141-153.
24. Hong Kong Chest Service/British Medical Research Council: Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First Report. Am Rev Respir Dis (1978) 118, 219-28.
25. British Thoracic Society: A controlled trial of 6 months chemotherapy in pulmonary tuberculosis. Final report: Results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest (1984) 78, 330-336.
26. Wada M, Yoshiyama T, Yoshikawa M, Ogata H, Sugie T, Nakasono T and Sugita H: Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis. Kekkaku (1994) 69, 671-680 (in Japanese, with English Abstract).
27. Aoki M: Practical use of medical care for tuberculosis; in Manual of Medical Care Standards of Tuberculosis. Kekkakuyoboukai, Tokyo (1997) pp67-75 (in Japanese).